NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the stylized wording "LBIOME" and design featuring the letters LB semi-connected and the letter O featured as a circle with ten small ovals, on a tilt, inside the circle.
Titulares
Representantes
Duane M. Byers Nixon & Vanderhye P.C.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, autisms, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, obsessive-compulsive disorders, addiction, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, necrotizing enterocolitis, enteritis, skin inflammation, and skin infections, and veterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, enteritis, skin inflammation, and skin infections; dietetic foods adapted for medical and veterinary use; bacterial preparations for medical and veterinary use; probiotic bacteria preparations for medical use; foodstuffs and nutritional and food supplements featuring live or inactivated microorganisms, namely, nutritional supplements, enzyme food supplements, dietary food supplements, food supplements for humans and animals; ingredients based on inactive bacteria preparations and heattreated and heat-stabilized bacteria preparations, namely, Lactobacillus strains in combination with fermentation medium featured as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; ingredients based on combinations of inactivated and heat-treated Lactobacillus delbrueckii and Lactobacillus fermentum and fermentation medium sold as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; additives in the nature of dietary supplements for humans or for animals; ferments for medical or veterinary use with postbiotic or probiotic effects
Classe 40
Customized manufacture, for third parties, of pharmaceuticals, nutritional and food supplements featuring live or inactivated microorganisms; manufacture of ingredients comprising inactivated, heat-treated Lactobacillus strains and their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; custom manufacture, for third parties, of pharmaceutical and nutritional supplemental ingredients, namely, enriched culture medium and heat-treated microorganisms; manufacture of pharmaceutical ingredients, namely, heat-treated micro-organisms, for preparation of tablets, capsules, powders, injectable products, suspensions, liquids, for medical and veterinary use
Classe 42
Medical and pharmaceutical research and development in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; scientific research and development; bacteriological scientific research and consultation; provision of information and data relating to medical and veterinary research and development; provision of scientific and technological information in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; design and development of pharmaceuticals, nutritional supplements and dietetic supplements comprising living and inactivated microorganisms; research and development of formulations, namely, pharmaceuticals, nutritional supplements, and dietary supplements for the administration of heat-treated Lactobacillus strains combined with their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; research and development of pharmaceutical ingredients based on enriched culture medium and heat-treated bacteria, namely, Lactobacillus strains; research and development of formulations, namely, pharmaceutials, nutritional supplements, and dietetic supplements, based on enriched culture medium and heat-treated micro-organisms; technological consultation in the field of bacteria-based ingredients and in the field of postbiotics
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2024
CHANGE OF NAME/ADDRESS REC'D FROM IB
19/07/2024
NEW REPRESENTATIVE AT IB RECEIVED
04/11/2023
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2023
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2023
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2023
FINAL DECISION TRANSACTION PROCESSED BY IB
20/08/2023
FINAL DISPOSITION NOTICE SENT TO IB
02/08/2023
FINAL DISPOSITION PROCESSED
02/08/2023
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/07/2023
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/04/2023
REGISTERED-PRINCIPAL REGISTER
25/04/2023
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/03/2023
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/02/2023
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/02/2023
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
07/02/2023
NOTIFICATION PROCESSED BY IB
07/02/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2023
PUBLISHED FOR OPPOSITION
07/02/2023
ASSIGNED TO PETITION STAFF
01/02/2023
POST PUBLICATION AMENDMENT RECEIVED
01/02/2023
ASSIGNED TO PETITION STAFF
30/01/2023
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/01/2023
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/01/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/01/2023
TEAS POST PUBLICATION AMENDMENT RECEIVED
17/01/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
31/12/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/12/2022
TEAS REQUEST FOR RECONSIDERATION RECEIVED
30/12/2022
NOTIFICATION OF FINAL REFUSAL EMAILED
03/09/2022
FINAL REFUSAL E-MAILED
03/09/2022
FINAL REFUSAL WRITTEN
03/09/2022
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2022
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2022
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/07/2022
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/07/2022
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/07/2022
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/07/2022
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/07/2022
REFUSAL PROCESSED BY IB
27/03/2022
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/03/2022
REFUSAL PROCESSED BY MPU
09/03/2022
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/02/2022
NON-FINAL ACTION WRITTEN
10/02/2022
ASSIGNED TO EXAMINER
01/02/2022
APPLICATION FILING RECEIPT MAILED
28/09/2021
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/09/2021
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/09/2021
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.